Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Hu Robotics secures 25 billion won in Series A funding led by Atinum Investment to advance wearable robotics development.

PRIVATEOct 14, 2026

Amount Raised

₩25 Billion

Round Type

Series A

South KoreaBiotechnologyHealth CareMedical DeviceRobotics

Investors

Mirae Asset Venture InvestmentLotteNaverDaewoongWonik Investment PartnersAju Ib InvestmentIndustrial Bank Of KoreaStonebridge VenturesAtinum Investment

Description

Hu Robotics, a soft exosuit specialist, raised 25 billion won in Series A funding led by Atinum Investment. The round included participation from existing investors such as Stonebridge Ventures, Industrial Bank of Korea, AJU IB Investment, and Wonik Investment Partners, as well as new strategic investors from healthcare, retail, and IT sectors including Daewoong, Naver, Lotte, and Mirae Asset Venture Investment. The funding brings the company's cumulative capital to over 33.5 billion won. Hu Robotics will use the capital to accelerate development of its walking-assistance robots, including its flagship H-Medi soft exosuit for medical gait rehabilitation.

Company Information

Company

Hu Robotics

Location

South Korea

About

Hu Robotics is a soft exosuit specialist founded in July 2022 that develops wearable robotic technology for medical gait rehabilitation and daily living assistance. The company's flagship product, H-Medi, is a cable-and-tendon actuated soft exosuit that has received medical device certification and is being used in hospitals for stroke rehabilitation. The company was founded by Lee Giuk, a professor at Chung-Ang University who previously led research on wearable robots at Harvard University's Wyss Institute. Hu Robotics plans to expand H-Medi's global distribution and develop H-Care, a wearable robot for everyday walking assistance.

Fundz sees it the moment Hu Robotics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Hu Robotics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Hu Robotics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.